Shanghai Iluvatar CoreX SemiCon Co saw its Hong Kong-listed shares rise 7.1% to HK$600 on Thursday following confirmation of a significantly upsized share placement that raised approximately HK$7.07 billion, equivalent to about US$902 million.
The company sold 14.9 million shares at HK$476 apiece, a price that represented about a 15% discount to the previous session's close. That placement price fell at the low end of the initially marketed HK$476 to HK$498.40 range. The sale raised materially more capital than earlier expectations, which had anticipated proceeds of around US$850 million.
Beyond the headline figure, the transaction has strategic implications. Iluvatar had been working with advisers on a potential placement after the six-month lock-up tied to its initial public offering expired only days before the deal was announced. The successful execution of the offering indicates meaningful investor appetite at the marketed price point.
Investor interest is being driven in part by the company’s reported commercial activity. Reports showed Iluvatar is in discussions to sell ByteDance at least 50,000 AI inference chips, a deal that would position the firm as an important supplier within ByteDance’s hardware ecosystem. The timing of the placement, combined with that reported negotiation, has contributed to the buying interest in the stock.
The broader market environment for Hong Kong-listed AI and semiconductor companies has been constructive. Artificial intelligence-related catalysts from major internet firms and a rotation of capital helped lift the Hang Seng Tech Index, which rallied nearly 5% on July 8 to close at 4,731 points. Market participants said risk appetite was supported by optimism around AI and technology, while a robust initial public offering pipeline in Hong Kong also added to positive sentiment.
Analyst coverage on Iluvatar remains positive. The average 12-month price target across six covering analysts stands at HK$762.15, and all six analysts recommend a Buy, resulting in an overall rating classified as Strong Buy. That consensus underscores the favorable view among sell-side analysts following the placement and the company’s reported commercial discussions.
Investors will likely watch how Iluvatar deploys the proceeds and whether the reported talks with ByteDance progress. For now, the combination of fresh capital, the expiration of the IPO lock-up, and sector-wide AI momentum appears to have driven renewed demand for the stock.